Li Dean Y 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Li Dean Y
Director
Transactions
- Award
Class A Common Stock
2025-10-01+1,961→ 1,238,528 total
Holdings
- 1,422,048(indirect: By Trust)
Class A Common Stock
- 421,000(indirect: By Trust)
Class A Common Stock
- 136,981(indirect: By Dean Y. Li GRAT)
Class A Common Stock
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.